Loading...
Loading...
Comprehensive Guide
Only 6.8% of American adults are metabolically healthy. Metabolic dysfunction drives heart disease, diabetes, neurodegeneration, and premature death. This guide gives you the science to understand it, the tests to measure it, and the protocols to optimize it.
5
Metabolic syndrome criteria
93%
Of US adults metabolically unwell
8
Key biomarkers to track
12
Week optimization protocol
The Foundation
Metabolic health is defined by 5 measurable criteria — meeting all 5 without medication means you are metabolically healthy. Failing any 3 of 5 qualifies as metabolic syndrome, a condition that doubles cardiovascular risk and increases all-cause mortality by 50%.
Metabolic Syndrome Threshold
Men: > 40 in (102 cm) | Women: > 35 in (88 cm)
Optimal Target
Men: < 35 in (89 cm) | Women: < 30 in (76 cm)
Waist circumference is a proxy for visceral fat — the metabolically active fat surrounding your organs. Visceral fat secretes inflammatory cytokines (TNF-alpha, IL-6), produces excess estrogen via aromatase, and drives insulin resistance directly through portal vein delivery of free fatty acids to the liver.
Metabolic Syndrome Threshold
> 100 mg/dL
Optimal Target
75-90 mg/dL
Elevated fasting glucose means your body cannot maintain glucose homeostasis overnight. By the time fasting glucose rises above 100 mg/dL, significant insulin resistance has already developed — your pancreas has been overproducing insulin for years to keep glucose in range, and it is now losing that battle.
Metabolic Syndrome Threshold
> 150 mg/dL
Optimal Target
< 80 mg/dL
High triglycerides reflect excess carbohydrate-to-fat conversion in the liver (de novo lipogenesis), driven by hyperinsulinemia and fructose consumption. They correlate directly with small dense LDL particles, liver fat accumulation (NAFLD), and cardiovascular risk. Triglycerides respond rapidly to dietary changes — often dropping 30-50% within weeks.
Metabolic Syndrome Threshold
Men: < 40 mg/dL | Women: < 50 mg/dL
Optimal Target
> 60 mg/dL
HDL particles perform reverse cholesterol transport — removing cholesterol from arterial walls and returning it to the liver. Low HDL is not just a risk factor; it reflects impaired lipid metabolism, often caused by high-carbohydrate diets, sedentary behavior, and insulin resistance. Exercise, omega-3s, and reducing refined carbs raise HDL effectively.
Metabolic Syndrome Threshold
> 130/85 mmHg
Optimal Target
< 120/80 mmHg
Hyperinsulinemia increases blood pressure through sodium retention (kidneys reabsorb more sodium under high insulin), sympathetic nervous system activation, and endothelial dysfunction (reduced nitric oxide production). Blood pressure is often the last criterion to normalize because it involves structural vascular changes that take months to reverse.
A landmark 2019 study (Araújo et al., Metabolic Syndrome and Related Disorders) analyzed NHANES data from 55,081 US adults and found that only 6.8% met all five criteria for metabolic health. Even among normal-weight adults, only 33% were metabolically healthy. Among overweight adults, just 9.6%. Among obese adults, 0.5%.
This means 93% of American adults have at least one metabolic dysfunction — and most do not know it because standard medical practice does not test fasting insulin, the earliest warning sign. By the time fasting glucose or HbA1c is elevated (the markers doctors typically check), insulin resistance has been present for 10-15 years.
The Root Cause
Insulin resistance is not a binary switch — it is a progressive cascade that develops over years, often silently. Understanding each stage helps you identify where you are and how to intervene before irreversible damage occurs.
Repeated high-glycemic meals drive frequent insulin spikes. The pancreas secretes insulin to shuttle glucose into cells. Over time, cells become saturated with glucose and begin downregulating insulin receptors — the beginning of resistance.
The pancreas compensates by producing more insulin to overcome the resistance. Blood glucose stays normal (for now), but insulin levels climb. This hidden hyperinsulinemia drives fat storage, inflammation, sodium retention, and accelerated aging — all while standard glucose tests look fine.
The liver becomes insulin resistant. It no longer suppresses glucose production in response to insulin, dumping glucose into the bloodstream even when blood sugar is already elevated. The liver also accelerates de novo lipogenesis (converting sugar to fat), leading to fatty liver (NAFLD) and elevated triglycerides.
Skeletal muscle — the largest glucose sink in the body — loses insulin sensitivity. GLUT4 transporter translocation to the cell surface is impaired. Glucose cannot enter muscle cells efficiently, so it stays in the bloodstream. This is why resistance training is so powerful: muscle contraction activates GLUT4 independently of insulin.
Fat cells become insulin resistant and can no longer store fat efficiently. Free fatty acids spill into the bloodstream (lipotoxicity), depositing as visceral fat around organs. Visceral adipocytes secrete inflammatory cytokines and adipokines, further worsening insulin resistance in a vicious cycle.
After years of compensatory overproduction, pancreatic beta cells begin to fail — either from exhaustion or glucotoxicity-induced apoptosis. Insulin production drops. Blood glucose now rises unchecked. This is the transition from prediabetes to type 2 diabetes. The goal is to intervene at stages 1-3, long before this point.
The most insidious aspect of insulin resistance is the compensatory hyperinsulinemia phase (stages 2-4). During this period — which can last 10-15 years — your blood glucose remains normal because your pancreas is overproducing insulin to compensate. Standard medical tests (fasting glucose, HbA1c) will show nothing wrong.
But elevated insulin is not benign. It drives: visceral fat storage, sodium retention (raising blood pressure), uric acid elevation, triglyceride overproduction, inflammatory cytokine release, endothelial dysfunction, and accelerated cellular aging through mTOR activation.
This is why fasting insulin is the most important metabolic test you can get — it catches the problem 10-15 years before glucose-based tests reveal it. If your fasting insulin is above 8 µIU/mL, insulin resistance has begun. Above 12 µIU/mL, it is well established.
The Goal
Metabolic flexibility is your body's ability to efficiently switch between burning fat and burning glucose depending on fuel availability and energy demand. It is the hallmark of metabolic health — and the opposite of metabolic syndrome.
Optimal fuel switching
Locked in glucose dependence
Metabolic flexibility is built by training both fuel systems. The primary tools are:
Real-Time Data
A continuous glucose monitor provides a glucose reading every 1-5 minutes via a small sensor on your arm — revealing the hidden glucose story that fasting blood tests miss.
Fasting Glucose (morning)
75-90 mg/dL
Measured immediately upon waking, before any food or activity.
Post-Meal Peak
< 140 mg/dL (ideally < 120)
Maximum glucose within 1-2 hours after eating. Peaks above 140 indicate poor glucose handling.
Post-Meal Return to Baseline
< 2 hours
Glucose should return to pre-meal levels within 2 hours. Prolonged elevation indicates insulin resistance.
24-Hour Average
85-100 mg/dL
Average glucose across 24 hours. Higher averages correlate with higher HbA1c and metabolic dysfunction.
Glycemic Variability (CV)
< 20%
Coefficient of variation. Low variability = stable glucose = metabolic flexibility. High variability = glucose rollercoaster.
Practical recommendation: Wear a CGM for 2-4 weeks as a learning experiment. Test your common meals, test the effect of walking after eating, test how sleep quality affects your glucose, and test your individual response to specific carbohydrate sources. Record your findings, then apply them permanently. You do not need to wear a CGM continuously — use it as a tool to build lasting knowledge about your body. Popular options include Levels, Nutrisense, and Signos (which pair CGMs with coaching).
Targeted Support
These compounds enhance glucose uptake, improve insulin sensitivity, or slow carbohydrate absorption. They work best on top of a solid dietary foundation — not as a replacement for it.
500 mg 2-3x daily with meals
Activates AMPK (AMP-activated protein kinase) — the master metabolic switch. Increases GLUT4 translocation, improves mitochondrial function, enhances GLP-1 secretion, and modulates gut microbiome. Meta-analysis of 14 RCTs: reduces fasting glucose by 15-25 mg/dL and HbA1c by 0.5-0.9%.
Comparable to metformin in head-to-head trials. Can cause GI upset at high doses — start at 500 mg once daily and titrate up. Do not combine with metformin without physician guidance. Cycles: 8 weeks on, 2 weeks off.
200-1,000 mcg daily
Essential trace mineral that enhances insulin receptor sensitivity by amplifying insulin signaling cascade. Improves GLUT4 translocation. Deficiency is common (estimated 50% of adults) and directly impairs glucose tolerance. RCTs show 15-20% improvement in fasting insulin.
Picolinate form has the best absorption. Most effective in those who are deficient. Higher doses (1,000 mcg) used in clinical trials for insulin resistance. Safe, no known toxicity at supplemental doses. Take with meals.
300-600 mg daily
Universal antioxidant (both water and fat soluble) that activates AMPK, enhances glucose uptake in skeletal muscle, regenerates other antioxidants (vitamin C, E, glutathione), and reduces oxidative stress in mitochondria. R-ALA is the biologically active form with 40-50% greater bioavailability.
R-ALA (R-lipoic acid) preferred over racemic ALA. Take on an empty stomach for best absorption. Particularly effective for diabetic neuropathy. Pairs synergistically with berberine.
1-3 g daily (or 500 mg extract)
Contains methylhydroxychalcone polymer (MHCP) which mimics insulin by activating insulin receptor and GLUT4. Slows gastric emptying, reducing post-meal glucose spikes. Also inhibits alpha-glucosidase enzymes, slowing carbohydrate digestion.
Must use Ceylon (Cinnamomum verum), not Cassia cinnamon which contains high levels of coumarin (hepatotoxic at high doses). Add to coffee, smoothies, or meals. Effects are modest but stack well with other agents.
300-400 mg elemental magnesium daily
Cofactor for over 600 enzymatic reactions including insulin signaling. Magnesium deficiency (affects 50%+ of adults) directly impairs insulin receptor tyrosine kinase activity, reducing insulin sensitivity. Every 100 mg/day increase in magnesium intake reduces diabetes risk by 15% (meta-analysis of 13 prospective studies).
Glycinate for absorption and sleep. Threonate for cognitive benefits. Avoid oxide (poor absorption). Intracellular magnesium is what matters — serum magnesium is a poor indicator. Most people need to supplement regardless of diet.
1-2 tablespoons in water before meals
Acetic acid slows gastric emptying, inhibits disaccharidase enzymes (slowing sugar digestion), and improves hepatic glucose uptake. RCTs show 20-35% reduction in post-meal glucose spike when consumed before a carbohydrate-rich meal.
Always dilute in water — undiluted vinegar damages tooth enamel and esophageal tissue. Use before your highest-carbohydrate meal of the day for maximum benefit. The effect is mechanical (slowing digestion), not hormonal.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
The Metabolic Engine
Skeletal muscle is the largest glucose-disposing organ in the body — responsible for 80% of insulin-stimulated glucose uptake. Building and using muscle is the most powerful metabolic intervention available.
GLUT4 is the glucose transporter protein stored inside muscle cells. Normally, insulin signals GLUT4 to move to the cell surface to allow glucose entry. In insulin resistance, this signaling is impaired.
The critical insight: muscle contraction activates GLUT4 independently of insulin. When you contract a muscle (walking, lifting, any movement), GLUT4 translocates to the cell surface through AMPK and calcium-dependent pathways — completely bypassing the broken insulin signaling. This is why walking after meals is so effective: it activates a glucose disposal pathway that works even when insulin resistance is present.
Furthermore, the GLUT4 translocation effect persists for 24-48 hours after exercise. A single resistance training session improves insulin sensitivity for up to 48 hours. This means consistent exercise (every 48 hours minimum) creates a continuous state of enhanced glucose disposal.
150+ min/week
3x/week compound movements
15 min after each meal
Think of skeletal muscle as a glucose sink — the larger the sink, the more glucose your body can dispose of without relying on insulin. This is why strength training is uniquely powerful for metabolic health: it increases the permanent capacity of your body to handle glucose. Every pound of muscle added is like expanding the size of your glucose storage tank.
This also explains why sarcopenia (age-related muscle loss) is a metabolic catastrophe. Losing muscle mass shrinks your glucose disposal capacity, contributing directly to the insulin resistance that increases with age. Resistance training is not optional for metabolic health — it is foundational.
Metabolic Reset
Beyond exercise and nutrition, several powerful tools directly reset metabolic machinery at the cellular level — repairing mitochondria, activating brown fat, and restoring insulin sensitivity.
The Power Plant
Mitochondria are the organelles that convert food into usable energy (ATP). Metabolic health IS mitochondrial health — when your mitochondria are dysfunctional, every metabolic process suffers.
Every cell in your body depends on mitochondria to produce ATP (adenosine triphosphate) — the universal energy currency. Your body produces approximately its own weight in ATP every single day. When mitochondria become dysfunctional — through aging, sedentary behavior, poor nutrition, or toxin exposure — energy production drops, reactive oxygen species (ROS) increase, and metabolic capacity declines.
Mitochondrial dysfunction is now recognized as a central mechanism in insulin resistance. Impaired mitochondria cannot efficiently oxidize fatty acids, leading to lipid accumulation inside muscle cells (intramyocellular lipids) which directly blocks insulin signaling. They also produce excess ROS, which damages insulin receptors and activates inflammatory pathways.
The good news: mitochondria are highly responsive to lifestyle interventions. You can increase mitochondrial density, improve their efficiency, and clear damaged ones (mitophagy) through the strategies below.
Sustained aerobic exercise at 60-70% max heart rate (nasal breathing, conversational pace) specifically targets mitochondrial biogenesis. This intensity preferentially stimulates Type I muscle fibers, increases mitochondrial density, improves fat oxidation capacity, and enhances the electron transport chain. 150-180 minutes per week minimum.
Cold activates PGC-1alpha — the master regulator of mitochondrial biogenesis — through AMPK and irisin signaling. Cold-induced shivering recruits and activates brown adipose tissue (BAT), which is dense with mitochondria containing UCP1. Regular cold exposure increases mitochondrial uncoupling and metabolic rate by 10-15%.
Fasting periods activate AMPK and inhibit mTOR, triggering mitophagy — the selective autophagy of damaged mitochondria. This quality control process removes dysfunctional mitochondria and stimulates biogenesis of new, efficient ones. A 16-hour overnight fast is sufficient to activate meaningful mitophagy.
Sauna use upregulates heat shock proteins (HSP60, HSP70) which serve as mitochondrial chaperones — ensuring proper folding of mitochondrial proteins and protecting the electron transport chain from oxidative damage. Regular sauna use (4x/week) increases PGC-1alpha expression and mitochondrial biogenesis.
NAD+ is the essential coenzyme for mitochondrial energy production (electron transport chain) and declines 50% by age 60. Supporting NAD+ through precursors like NMN (250-500 mg) or NR (300-600 mg), combined with lifestyle factors that preserve NAD+ (exercise, fasting, avoiding alcohol), maintains mitochondrial function with age.
Near-infrared light (660-850nm) is absorbed by cytochrome c oxidase (Complex IV) in the electron transport chain, directly increasing ATP production by 30-50% in irradiated tissues. Morning sunlight also sets the circadian clock that regulates mitochondrial fission/fusion cycles, ensuring peak energy production during waking hours.
The Metabolic Saboteur
Visceral fat — the fat deposited around your abdominal organs — is not just stored energy. It is an active endocrine organ that secretes hormones, inflammatory cytokines, and metabolic toxins that actively drive disease.
Subcutaneous fat (under the skin) is relatively benign — it stores energy and produces leptin. Visceral fat is metabolically active and dangerous. It secretes: TNF-alpha (drives insulin resistance), IL-6 (systemic inflammation), resistin (blocks insulin receptor signaling), PAI-1 (promotes blood clotting), and excess estrogen via aromatase enzyme activity.
Visceral fat also drains directly into the portal vein, delivering free fatty acids and inflammatory mediators straight to the liver — contributing to non-alcoholic fatty liver disease (NAFLD), which affects 25% of the global population and is now the leading cause of liver disease.
The critical insight: you cannot assess visceral fat with a scale. A DEXA scan with visceral fat estimation, or waist circumference as a proxy, are the only reliable assessments. Many “normal weight” individuals carry dangerous levels of visceral fat.
Fasting lowers insulin, the master fat-storage hormone. Low insulin enables lipolysis (fat breakdown), and visceral fat is preferentially mobilized first because it has more beta-adrenergic receptors and higher blood flow than subcutaneous fat.
Builds metabolically active muscle that burns glucose and fatty acids at rest. Each pound of muscle increases daily metabolic rate by 6-10 calories. Resistance training also directly reduces visceral fat independent of total weight loss — the composition shifts from fat to muscle.
Preferentially burns fat as fuel (at this intensity, 60-70% of calories come from fat oxidation). Increases mitochondrial density, improving the body's capacity to oxidize fatty acids. Visceral fat stores are depleted before subcutaneous stores due to their higher metabolic activity.
Activates brown adipose tissue and induces browning of white adipose tissue (beiging), increasing uncoupled thermogenesis. Cold-induced norepinephrine directly activates lipolysis in visceral fat depots. Regular cold exposure increases resting metabolic rate by 10-15%.
Fructose is metabolized exclusively by the liver, where excess is converted to fat via de novo lipogenesis and preferentially stored as visceral fat. Removing fructose (especially HFCS in processed food) reduces hepatic fat production and allows visceral stores to deplete.
Chronic cortisol specifically promotes visceral fat deposition through cortisol receptors concentrated in visceral adipose tissue (4x more than subcutaneous fat). Reducing cortisol through meditation, breathwork, and sleep optimization preferentially reduces visceral fat accumulation.
Targeted Support
These supplements support metabolic health by improving insulin sensitivity, mitochondrial function, and glucose handling. They work best layered on top of the lifestyle interventions described above.
500 mg 2-3x daily with meals
Activates AMPK, the master metabolic switch. Increases GLUT4 translocation to cell membranes, enhances mitochondrial biogenesis, improves gut microbiome diversity, and stimulates GLP-1 secretion. Lowers fasting glucose, HbA1c, triglycerides, and LDL in multiple meta-analyses. The most comprehensively studied natural glucose-lowering agent.
Start low (500 mg once daily) to assess GI tolerance. Cycle 8 weeks on, 2 weeks off. Do not combine with metformin without physician supervision. Take with meals to reduce GI side effects and maximize glucose-lowering effect.
300-400 mg elemental magnesium daily
Essential cofactor for insulin receptor signaling and over 600 enzymatic reactions. Deficiency directly impairs insulin sensitivity, increases oxidative stress, and promotes inflammation. Meta-analysis: 100 mg/day increase reduces diabetes risk by 15%. Also improves sleep quality and reduces cortisol — both of which affect metabolic health.
Glycinate for absorption, relaxation, and sleep support. Threonate crosses the blood-brain barrier for cognitive benefits. Most people are deficient regardless of diet. Split dose between morning and evening.
2-4 g combined EPA+DHA daily
Reduces hepatic triglyceride synthesis (de novo lipogenesis), improves cell membrane fluidity (enhancing insulin receptor function), produces anti-inflammatory resolvins, and activates PPARs (peroxisome proliferator-activated receptors) which regulate fat and glucose metabolism. High-dose EPA specifically reduces triglycerides by 30-45%.
Triglyceride form absorbs 70% better than ethyl ester. Take with a fat-containing meal. IFOS-certified for purity. Target EPA greater than 1,500 mg/day for metabolic benefit. Monitor omega-3 index — aim for greater than 8%.
200-1,000 mcg daily
Enhances insulin receptor sensitivity by potentiating insulin signaling. Improves GLUT4 translocation to cell membranes. Chromium deficiency (common with modern diets) directly impairs glucose tolerance. Most effective in individuals who are deficient, which is likely the majority of adults eating a processed food diet.
Picolinate form has the best bioavailability. Safe at supplemental doses — no known toxicity up to 1,000 mcg. Take with meals. Effects are modest individually but compound with other interventions.
300-600 mg R-ALA daily
Universal antioxidant that activates AMPK (similar to berberine), enhances glucose uptake in skeletal muscle independently of insulin, regenerates other antioxidants (vitamins C, E, glutathione), and reduces mitochondrial oxidative stress. R-form is 40-50% more bioavailable than racemic ALA.
Take on an empty stomach for best absorption. R-ALA preferred over standard ALA. Particularly studied for diabetic neuropathy. Synergistic with berberine and chromium. Stabilized R-ALA (Na-R-ALA) has superior shelf stability.
100-300 mg ubiquinol daily
Essential electron carrier in the mitochondrial electron transport chain — directly required for ATP production. CoQ10 levels decline with age and are depleted by statin medications. Supplementation improves mitochondrial efficiency, reduces oxidative stress, and improves endothelial function (blood pressure). Multiple trials show improvement in fasting glucose and HbA1c.
Ubiquinol (reduced form) absorbs 3-8x better than ubiquinone. Fat-soluble — take with a meal. Essential if on statin medications (statins block the same pathway that produces CoQ10). Kaneka Ubiquinol is the most studied branded form.
5,000 IU D3 + 100-200 mcg K2 (MK-7) daily
Vitamin D receptors are present on pancreatic beta cells and directly regulate insulin secretion. Deficiency (affecting 40-50% of adults) impairs insulin sensitivity and increases diabetes risk. Meta-analysis shows vitamin D supplementation reduces progression from prediabetes to diabetes by 12%. K2 directs calcium to bones and away from arteries.
Test before supplementing and adjust dose to achieve blood levels of 50-80 ng/mL. Fat-soluble — take with a meal. Most people require 5,000 IU daily to reach optimal levels. K2 as MK-7 has the longest half-life.
Disclaimer: Supplements are not a replacement for medical treatment. Always consult your healthcare provider before starting a new supplement regimen, especially if you take medications or have existing conditions. Berberine in particular has drug interactions (metformin, statins, blood thinners). See our full disclaimer.
Measure It
You cannot optimize what you do not measure. These 8 markers give you a comprehensive picture of your metabolic status — including the early-warning markers that standard check-ups miss.
| Biomarker | Standard Range | Optimal Range |
|---|---|---|
Fasting Insulin Fasting Insulin | 2.6 – 24.9 μIU/mL | < 5 μIU/mL |
HOMA-IR Homeostatic Model Assessment of Insulin Resistance | < 2.5 | < 1.0 |
HbA1c Glycated Hemoglobin | < 5.7% (prediabetes: 5.7-6.4%) | 4.8-5.2% |
Triglycerides Serum Triglycerides | < 150 mg/dL | < 80 mg/dL |
HDL Cholesterol High-Density Lipoprotein Cholesterol | Men: > 40 mg/dL | Women: > 50 mg/dL | > 60 mg/dL |
Fasting Glucose Fasting Plasma Glucose | < 100 mg/dL (prediabetes: 100-125) | 75-90 mg/dL |
Uric Acid Serum Uric Acid | Men: 3.0-7.0 mg/dL | Women: 2.5-6.0 mg/dL | < 5.5 mg/dL |
hs-CRP High-Sensitivity C-Reactive Protein | < 3.0 mg/L | < 0.5 mg/L |
Fasting Insulin
Fasting Insulin
The earliest marker of metabolic dysfunction. Rises 10-15 years before blood glucose becomes abnormal. Reflects the degree of insulin resistance — how hard your pancreas is working to maintain glucose homeostasis.
Standard
2.6 – 24.9 μIU/mL
Optimal
< 5 μIU/mL
Standard blood draw after 12-hour fast. Request specifically — not included in a basic metabolic panel. The single most important metabolic marker most doctors fail to order.
HOMA-IR
Homeostatic Model Assessment of Insulin Resistance
Calculated from fasting insulin and fasting glucose: (insulin x glucose) / 405. The gold-standard clinical estimate of insulin resistance. More informative than either fasting insulin or glucose alone because it captures the relationship between the two.
Standard
< 2.5
Optimal
< 1.0
Calculated from fasting insulin + fasting glucose (both from the same blood draw). Some labs calculate it automatically; otherwise calculate it yourself.
HbA1c
Glycated Hemoglobin
Average blood glucose over the past 2-3 months, measured as the percentage of hemoglobin molecules with glucose attached. Reflects cumulative glycemic exposure, not a single point in time. Insensitive to day-to-day variation.
Standard
< 5.7% (prediabetes: 5.7-6.4%)
Optimal
4.8-5.2%
Standard blood draw, no fasting required. Included in many annual panels. Can be falsely low in conditions that accelerate red blood cell turnover (hemolytic anemia, blood loss).
Triglycerides
Serum Triglycerides
Blood fat levels, primarily reflecting hepatic de novo lipogenesis (conversion of excess carbohydrates to fat). A direct metabolic readout — triglycerides respond to dietary changes within 1-2 weeks. The TG:HDL ratio is a powerful proxy for insulin resistance.
Standard
< 150 mg/dL
Optimal
< 80 mg/dL
Standard lipid panel after 12-hour fast. Always ordered as part of cholesterol testing. Calculate TG:HDL ratio yourself — optimal is below 1.0.
HDL Cholesterol
High-Density Lipoprotein Cholesterol
Reverse cholesterol transport capacity. Low HDL reflects impaired lipid metabolism, often caused by insulin resistance, high-carbohydrate diets, sedentary behavior, and visceral adiposity. HDL is protective — it removes cholesterol from arterial walls.
Standard
Men: > 40 mg/dL | Women: > 50 mg/dL
Optimal
> 60 mg/dL
Standard lipid panel. Raise HDL through: regular exercise, omega-3 fatty acids, reducing refined carbohydrates, moderate alcohol (controversial), and losing visceral fat.
Fasting Glucose
Fasting Plasma Glucose
Blood sugar after a 12-hour overnight fast. Reflects hepatic glucose output and baseline insulin sensitivity. Notably, this is a late-stage marker — by the time fasting glucose is elevated, insulin resistance has been present for years (hidden by compensatory hyperinsulinemia).
Standard
< 100 mg/dL (prediabetes: 100-125)
Optimal
75-90 mg/dL
Standard blood draw after 12-hour fast. Included in basic metabolic panel (BMP). Inexpensive and universally available. More useful when paired with fasting insulin to calculate HOMA-IR.
Uric Acid
Serum Uric Acid
End product of purine metabolism. Increasingly recognized as a metabolic marker — elevated uric acid drives insulin resistance, oxidative stress, endothelial dysfunction, and activates NF-kB inflammatory pathways. Strongly correlated with fructose consumption and metabolic syndrome.
Standard
Men: 3.0-7.0 mg/dL | Women: 2.5-6.0 mg/dL
Optimal
< 5.5 mg/dL
Standard blood draw. Often included in comprehensive metabolic panels. Reduce through: eliminating fructose/sucrose, limiting alcohol (especially beer), increasing hydration, and tart cherry extract supplementation.
hs-CRP
High-Sensitivity C-Reactive Protein
Systemic inflammation — the metabolic-inflammation connection. Chronic metabolic dysfunction drives inflammation (via visceral fat cytokines, hyperinsulinemia, and oxidized lipids), and inflammation worsens metabolic dysfunction. Tracking hs-CRP alongside metabolic markers reveals this bidirectional relationship.
Standard
< 3.0 mg/L
Optimal
< 0.5 mg/L
Standard blood draw. Request high-sensitivity CRP specifically. Elevated hs-CRP with metabolic dysfunction suggests the inflammatory-metabolic vicious cycle is active.
HOMA-IR
= (Fasting Insulin x Fasting Glucose) / 405
Optimal: < 1.0 | Insulin resistant: > 2.5
TG:HDL Ratio
= Triglycerides / HDL Cholesterol
Optimal: < 1.0 | Insulin resistant: > 3.0
Testing strategy: Get a comprehensive baseline before starting any protocol. Retest at 12 weeks to measure progress. Then test quarterly while actively optimizing, and biannually once markers are stable in the optimal range. Always test fasting (12-hour overnight fast) and in a rested state (no intense exercise within 48 hours) for consistent results.
Your Action Plan
This progressive protocol builds systematically — each phase compounds the benefits of the one before it. Do not skip phases or try to implement everything at once.
Weeks 1-4 — Remove the metabolic stressors
The goal is to lower baseline insulin and stop driving metabolic dysfunction. Most people notice improved energy stability, reduced cravings, and better sleep within 1-2 weeks. Fasting insulin typically begins dropping within the first 2-3 weeks.
Weeks 5-8 — Activate metabolic pathways
This phase adds the active interventions that build metabolic capacity — resistance training for GLUT4 activation, Zone 2 for mitochondrial density, cold for brown fat, and targeted supplementation. Each new tool activates specific molecular pathways that compound together.
Weeks 9-12 — Fine-tune and personalize
At this level you are deploying the full metabolic optimization stack — exercise, nutrition, fasting, cold, heat, supplementation, and data-driven personalization through CGM and blood testing. Compare your 12-week labs to baseline. Most people see dramatic improvement in HOMA-IR, triglycerides, HbA1c, and fasting insulin.
FAQ
Inflammation
Metabolic dysfunction and inflammation are bidirectional. Tackle both simultaneously for maximum impact.
Fasting
Deep dive into time-restricted eating, extended fasting, autophagy, and metabolic reset protocols.
Biomarkers
The 20 key metrics to track for healthspan, including all metabolic markers with optimal ranges.
This guide gives you the science. A CryoCove coach gives you the personalization — which labs to order, how to interpret your results, what to prioritize based on your data, and ongoing accountability as your metabolic markers improve.